EUVIMEDEUVIMED entdecken
Editorial

Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?

W Bryan Burnette iD

Muscle & Nerve · 2024

DOI: 10.1002/mus.28107 ↗

Kurz gefasst

Editorial in der Zeitschrift Muscle & Nerve, 2024. Verfasst von W Bryan Burnette. Beteiligte Einrichtung: Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneHumansMorpholinosMaleChildSteroids

Substanzen

eteplirsenMorpholinosSteroids

Autor:innen und Institutionen

  • Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: W Bryan Burnette

Zitieren

APA

Burnette, W. B. (2024). Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. https://doi.org/10.1002/mus.28107

Vancouver

Burnette WB. Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. 2024. doi:10.1002/mus.28107

BibTeX
@article{Burnette2024,
  author = {Burnette, W Bryan},
  title = {Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?},
  journal = {Muscle & Nerve},
  year = {2024},
  doi = {10.1002/mus.28107}
}
Kostenlos starten →